Page last updated: 2024-11-03

propafenone and Embryopathies

propafenone has been researched along with Embryopathies in 2 studies

Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.

Research Excerpts

ExcerptRelevanceReference
"In cases of non-immune hydrops fetalis caused by tachyarrhythmias, the transplacental passage of antiarrhythmic drugs may be hampered."1.27Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs. ( Bald, R; Gembruch, U; Hansmann, M, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fish, FA1
Mehta, AV1
Johns, JA1
Gembruch, U1
Hansmann, M1
Bald, R1

Other Studies

2 other studies available for propafenone and Embryopathies

ArticleYear
Characteristics and management of chaotic atrial tachycardia of infancy.
    The American journal of cardiology, 1996, Nov-01, Volume: 78, Issue:9

    Topics: Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Female; Fetal Diseases; Heart Defects, Cong

1996
Direct intrauterine fetal treatment of fetal tachyarrhythmia with severe hydrops fetalis by antiarrhythmic drugs.
    Fetal therapy, 1988, Volume: 3, Issue:4

    Topics: Anti-Arrhythmia Agents; Female; Fetal Diseases; Flecainide; Humans; Hydrops Fetalis; Medigoxin; Preg

1988